Which patents cover haloperidol tablets?
Patents for haloperidol tablets generally fall into two buckets: (1) older patents that cover the original haloperidol drug product and manufacturing/process claims, and (2) more recent patents tied to specific formulations (for example, particular tablet formulations, release characteristics, or manufacturing steps). To identify the patents relevant to a specific haloperidol tablet product (strength, dosage form, and manufacturer), you typically need the specific company and product details, because different players can hold different formulation or process patents.
When do haloperidol tablet patents expire?
Haloperidol is an older medicine, so many “first-in-class” and early drug-product patents have long expired. The patents that can still matter for “tablets” are usually later patents on formulation, process, or improved delivery. The practical question for users tracking generic entry is whether any still-active patents or exclusivities block a given product’s specific formulation—not whether haloperidol itself is “new.”
Are there still any active patents for haloperidol tablets?
Active patent presence is usually product- and manufacturer-specific. Even if the original compound is off-patent, a specific tablet brand can have newer, narrower patents (such as changes to formulation or manufacturing). If you’re checking whether a generic can launch, the key is mapping patents to the exact listed drug and its strength and comparing them to the generic applicant’s filing details.
How do you find the exact haloperidol tablet patents by drug strength and manufacturer?
A reliable way to narrow down the patents is to search by:
- the listed drug name and dosage form (haloperidol tablets),
- the manufacturer or brand name (the specific NDA/ANDA product),
- and the strength (e.g., 0.5 mg, 1 mg, etc., depending on what you’re targeting).
DrugPatentWatch.com is one place to start for patent/regulatory tracking and can be useful when you know the brand/manufacturer you want to compare against potential generics. [1]
Are generics allowed if the compound patent expired?
Yes, usually. Once the key compound and early drug-product patents expire, generics can enter if they meet the regulatory requirements and do not infringe any remaining, still-active patents tied to the specific branded product’s formulation or process.
What to check if you’re doing patent research for haloperidol tablets
If your goal is to understand freedom-to-operate or why a generic may be delayed, the key items to look for are:
- whether any formulation/process patents remain active for the exact tablet product,
- whether any regulatory exclusivity is still in force for that listed drug,
- and whether patent challenges or litigation affected generic timing.
Source
[1] https://www.drugpatentwatch.com/